论文信息 - Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status - 字舞流文

Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

Yi-long Wu | Jin-Ji Yang | Xue-Ning Yang | W. Zhong | Xuchao Zhang | Q. Nie | S. Dong | Hong-Hong Yan | Zhi-hong Chen | Qing Zhou | R. Liao | H. Tu | J. Su | Hong-Hong Yan